Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

See omnystudio.com/listener for privacy information.